Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Histomorphometry Assessment for Incident Dialysis Patients with Secondary Hyperparathyroidism Treated with Cinacalcet
2005-004643-53Phase 2Completed
- Sponsor
- Amgen
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), renal osteodystrophy and chronic kidney disease (CKD), sponsored by Amgen. Primary endpoint: Primary bone histomorphometric parameters. Started Jan 2006; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)renal osteodystrophychronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-004643-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004643-53.